News | January 08, 2015

Medtronic - Covidien: Beyond Taxes, Deal Will Create Patient Monitoring Power

Covidien's inpatient-centric remote patient monitoring complements Medtronic's home care-centric portfolio

Patient Monitoring, Remote Monitoring

Image courtesy of Covidien

January 8, 2015 — Medtronic's roughly $43 billion acquisition and merger with Covidien has been widely discussed in the media for its U.S. Federal tax implications, but it's also creating a stronger leading player in one of the fastest growing device markets, according to Kalorama Information. The healthcare market research firm said the two companies compete in patient monitoring systems will feature a diverse set of solutions spanning inpatient to home care, and cardiac to respiratory and blood-based monitoring.

Vendor product overviews, market segmentation and market share analysis within advanced remote patient monitoring is available from Kalorama Information in its latest report: Advanced Remote Patient Monitoring Systems, 7th Ed.

The remote patient monitoring market includes wireless and remote devices and technologies that monitor and transmit data through an internal network or secure wireless transmissions. The market includes the devices and associated systems to deliver current or real-time patient data outside of the patient room or from the home.

A core patient monitoring product for Covidien is its Vital Sync virtual patient monitoring system that provides integrated ventilator, pulse oximeter and capnography data to a central station or other access point for clinicians. Other Covidien patient monitoring products are in the respiratory function market segment and include Capnostream (portable and beside capnography or respiratory carbon dioxide monitors), Nellcore (pulse oximetry devices) and BIS monitors (measures patient consciousness under anesthesia).

Medtronic's strengths in advanced remote patient monitoring relate to the transmission and management of implantable and on-patient device-generated data. Medtronic's CareLink Network is able to deliver data from implantable pacemakers and defibrillators with cardiac resynchronization features, insulin pumps and continuous glucose monitoring devices. The devices and systems are relevant to the cardiac event and function and blood management and function (diabetes monitoring) market segments under advanced remote patient monitoring.

For more information:,,


Related Content

First-in-Human Results Show Early Bird Device Effective in Early Detection of Internal Bleeding
News | Patient Monitors | June 18, 2019
New study results validate the effectiveness of the Saranas Early Bird Bleed Monitoring System to sense bleeding events...
Lexington Biosciences Concludes Initial HeartSentry Clinical Study
News | Patient Monitors | August 16, 2018
Lexington Biosciences Inc. recently announced the completion of the initial HeartSentry study conducted at San...
Itamar Medical Launches SleePath for AFib Patients at Heart Rhythm 2018
Technology | Patient Monitors | May 16, 2018
Itamar Medical Ltd. announced the launch of SleePath, the first integrated e-health sleep apnea care pathway monitoring...
News | Patient Monitors | March 09, 2018
Philips recently announced the integration of its IntelliVue Guardian with automated Early Warning Scoring (EWS) into...
Acarix, CADScor System, coronary artery disease detection, clinical study, ACC.17
News | Patient Monitors | March 30, 2017
Acarix AB recently announced the results from a new multi-center trial of its handheld CADScor System for non-invasive...
Corsens Medical, Corsens Cardiac Monitor, FDA 510(k) clearance
Technology | Patient Monitors | December 08, 2016
Corsens Medical Ltd. announced that it has received clearance for a Pre-Marketing Notification (510(k)) with the U.S....
Corsens Cardiac Monitor, FDA 510k pre-market notification
News | Patient Monitors | May 26, 2016
Corsens Medical Ltd. announced it has successfully completed filing of a Pre-Marketing Notification (510(k)) with the U...
Philips, FDA 510k clearance, Expression MR400, MRI patient monitor
Technology | Patient Monitors | February 11, 2016
Royal Philips announced U.S. Food and Drug Administration (FDA) 510(k) clearance for the Expression MR400, a new...
Profusa, integrated biosensors, long-term continuous monitoring
News | Patient Monitors | January 15, 2016
Biointegrated sensors for long-term, continuous tracking of body chemistry may make health and disease monitoring as...
sleep apnea, pulse oximetery, congestive heart failure, CHF, pulse-oximetry, Thomas Jefferson University
News | Patient Monitors | September 09, 2015
Researchers at Thomas Jefferson University showed that a simple questionnaire, evaluation and pulse-oximetry monitoring...